190 related articles for article (PubMed ID: 15745044)
1. Prospects for hepatitis C vaccine.
Bhopale GM; Nanda RK
Acta Virol; 2004; 48(4):215-21. PubMed ID: 15745044
[TBL] [Abstract][Full Text] [Related]
2. Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens.
Vidalin O; Fournillier A; Renard N; Chen M; Depla E; Boucreux D; Brinster C; Baumert T; Nakano I; Fukuda Y; Liljeström P; Trépo C; Inchauspé G
Virology; 2000 Oct; 276(2):259-70. PubMed ID: 11040118
[TBL] [Abstract][Full Text] [Related]
3. A novel hepatitis C virus vaccine approach using recombinant Bacillus Calmette-Guerin expressing multi-epitope antigen.
Wei SH; Yin W; An QX; Lei YF; Hu XB; Yang J; Lu X; Zhang H; Xu ZK
Arch Virol; 2008; 153(6):1021-9. PubMed ID: 18421415
[TBL] [Abstract][Full Text] [Related]
4. HCV-NS3 Th1 minigene vaccine based on invariant chain CLIP genetic substitution enhances CD4(+) Th1 cell responses in vivo.
Gao M; Wang HP; Wang YN; Zhou Y; Wang QL
Vaccine; 2006 Jun; 24(26):5491-7. PubMed ID: 16725235
[TBL] [Abstract][Full Text] [Related]
5. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
[TBL] [Abstract][Full Text] [Related]
6. Vaccine development for hepatitis C.
Lechmann M; Liang TJ
Semin Liver Dis; 2000; 20(2):211-26. PubMed ID: 10946425
[TBL] [Abstract][Full Text] [Related]
7. Development of a heterologous, multigenotype vaccine against hepatitis C virus infection.
Encke J; Radunz W; Eisenbach C; Geib J; Gehrke S; Pfaff E; Stremmel W
Eur J Clin Invest; 2007 May; 37(5):396-406. PubMed ID: 17461986
[TBL] [Abstract][Full Text] [Related]
8. Recombinant retrovirus-like particle forming DNA vaccines in prime-boost immunization and their use for hepatitis C virus vaccine development.
Desjardins D; Huret C; Dalba C; Kreppel F; Kochanek S; Cosset FL; Tangy F; Klatzmann D; Bellier B
J Gene Med; 2009 Apr; 11(4):313-25. PubMed ID: 19248137
[TBL] [Abstract][Full Text] [Related]
9. Vaccines and immunotherapies against hepatitis B and hepatitis C viruses.
Inchauspé G; Michel ML
J Viral Hepat; 2007 Nov; 14 Suppl 1():97-103. PubMed ID: 17958650
[TBL] [Abstract][Full Text] [Related]
10. Codelivery of PEG-IFN-alpha inhibits HCV DNA vaccine-induced T cell responses but not humoral responses in African green monkeys.
Park SH; Lee SR; Hyun BH; Kim BM; Sung YC
Vaccine; 2008 Jul; 26(32):3978-83. PubMed ID: 18556097
[TBL] [Abstract][Full Text] [Related]
11. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of immune responses induced by recombinant attenuated Salmonella typhi carrying eukaryotic expression plasmid or prokaryotic expression plasmid of HCV core protein].
Chen ZH; Zhao P; Wu SM; Cao J; Zhang B; Wan MB; Ke JS; Qi ZT
Sheng Wu Gong Cheng Xue Bao; 2007 Sep; 23(5):862-6. PubMed ID: 18051866
[TBL] [Abstract][Full Text] [Related]
13. Differential antigenic hierarchy associated with spontaneous recovery from hepatitis C virus infection: implications for vaccine design.
Smyk-Pearson S; Tester IA; Lezotte D; Sasaki AW; Lewinsohn DM; Rosen HR
J Infect Dis; 2006 Aug; 194(4):454-63. PubMed ID: 16845628
[TBL] [Abstract][Full Text] [Related]
14. Advances in hepatitis C virus vaccines, part two: advances in hepatitis C virus vaccine formulations and modalities.
Roohvand F; Kossari N
Expert Opin Ther Pat; 2012 Apr; 22(4):391-415. PubMed ID: 22455502
[TBL] [Abstract][Full Text] [Related]
15. Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses.
Houghton M
Immunol Rev; 2011 Jan; 239(1):99-108. PubMed ID: 21198667
[TBL] [Abstract][Full Text] [Related]
16. Prospects for a vaccine against the hepatitis C virus.
Houghton M; Abrignani S
Nature; 2005 Aug; 436(7053):961-6. PubMed ID: 16107836
[TBL] [Abstract][Full Text] [Related]
17. [The development of therapeutic vaccine for hepatitis C virus].
Kimura K; Kohara M
Gan To Kagaku Ryoho; 2012 Oct; 39(10):1451-7. PubMed ID: 23064054
[TBL] [Abstract][Full Text] [Related]
18. Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.
Torresi J; Johnson D; Wedemeyer H
J Hepatol; 2011 Jun; 54(6):1273-85. PubMed ID: 21236312
[TBL] [Abstract][Full Text] [Related]
19. A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.
Folgori A; Capone S; Ruggeri L; Meola A; Sporeno E; Ercole BB; Pezzanera M; Tafi R; Arcuri M; Fattori E; Lahm A; Luzzago A; Vitelli A; Colloca S; Cortese R; Nicosia A
Nat Med; 2006 Feb; 12(2):190-7. PubMed ID: 16462801
[TBL] [Abstract][Full Text] [Related]
20. [Immunology of hepatitis C: clinical significance of T cell response].
Shin EC
Korean J Hepatol; 2006 Jun; 12(2):140-53. PubMed ID: 16804339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
